Legal Advantage Investments’s Idexx Laboratories IDXX Stock Holding History

Legal Advantage Investments’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.35M	Hold	6,360	–	–	1.17%	25
2026 Q1	$3.57M	Hold	6,360	–	–	1.85%	22
2025 Q4	$4.3M	Hold	6,360	–	–	1.99%	20
2025 Q3	$4.06M	Sell	6,360 -35	-0.5%	-$21.2K	1.83%	23
2025 Q2	$3.43M	Hold	6,395	–	–	1.6%	26
2025 Q1	$2.69M	Buy	6,395 +100	+2%	+$43.4K	1.45%	26
2024 Q4	$2.6M	Buy	6,295 +1,440	+30%	+$632K	1.38%	26
2024 Q3	$2.45M	Sell	4,855 -135	-3%	-$65.6K	1.35%	27
2024 Q2	$2.43M	Hold	4,990	–	–	1.4%	23
2024 Q1	$2.69M	Hold	4,990	–	–	1.51%	21
2023 Q4	$2.77M	Buy	4,990 +30	+0.6%	+$14.1K	1.66%	18
2023 Q3	$2.17M	Buy	4,960 +360	+8%	+$180K	1.55%	19
2023 Q2	$2.31M	Buy	+4,600	New	+$2.2M	1.54%	19

Other funds holding IDXX

MBI

Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $10.3B AUM 3.26% 1-Year Est. Return

Legal Advantage Investments's IDXX Position: Q2 2026 in Review

Legal Advantage Investments held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 6,360 shares worth $3.35M. The position accounts for 1.17% of the portfolio, ranked #25.

Legal Advantage Investments first reported a position in IDXX in Q2 2023 and has held it in 13 quarters since. The position peaked at $4.3M in Q4 2025. 509 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Legal Advantage Investments held 6,360 shares of Idexx Laboratories worth $3.35M as of Q2 2026.
Legal Advantage Investments left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up 1.17% of Legal Advantage Investments's portfolio in Q2 2026, its #25 holding.
Legal Advantage Investments first reported a position in Idexx Laboratories in Q2 2023 and has held it in 13 quarters since.
Legal Advantage Investments's Idexx Laboratories position peaked at $4.3M in Q4 2025.
509 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Legal Advantage Investments's 13F filing for Q2 2026, filed 15 Jul 2026.